Daniel D. Long, the SVP of $SEPN, sold 3,501 shares of the company on 11-10-2025 for an estimated $63,223. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.6% of their shares of this class of stock. Following this trade, they now own 92,911 shares of this class of $SEPN stock.
$SEPN Insider Trading Activity
$SEPN insiders have traded $SEPN stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $SEPN stock by insiders over the last 6 months:
- DANIEL D. LONG (SVP, Drug Discovery) sold 3,501 shares for an estimated $63,223
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$SEPN Hedge Fund Activity
We have seen 19 institutional investors add shares of $SEPN stock to their portfolio, and 18 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SIO CAPITAL MANAGEMENT, LLC removed 395,236 shares (-67.6%) from their portfolio in Q3 2025, for an estimated $7,434,389
- INVESCO LTD. added 165,237 shares (+1396.4%) to their portfolio in Q3 2025, for an estimated $3,108,107
- VANGUARD GROUP INC added 104,394 shares (+7.4%) to their portfolio in Q3 2025, for an estimated $1,963,651
- BLACKROCK, INC. added 68,995 shares (+5.0%) to their portfolio in Q3 2025, for an estimated $1,297,795
- STONEPINE CAPITAL MANAGEMENT, LLC removed 68,084 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $719,647
- GEODE CAPITAL MANAGEMENT, LLC added 57,745 shares (+11.8%) to their portfolio in Q3 2025, for an estimated $1,086,183
- NUVEEN, LLC removed 34,010 shares (-58.7%) from their portfolio in Q3 2025, for an estimated $639,728
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$SEPN Analyst Ratings
Wall Street analysts have issued reports on $SEPN in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Cantor Fitzgerald issued a "Overweight" rating on 09/05/2025
- HC Wainwright & Co. issued a "Buy" rating on 08/21/2025
To track analyst ratings and price targets for $SEPN, check out Quiver Quantitative's $SEPN forecast page.
$SEPN Price Targets
Multiple analysts have issued price targets for $SEPN recently. We have seen 2 analysts offer price targets for $SEPN in the last 6 months, with a median target of $27.5.
Here are some recent targets:
- Raghuram Selvaraju from HC Wainwright & Co. set a target price of $30.0 on 11/11/2025
- Josh Schimmer from Cantor Fitzgerald set a target price of $25.0 on 09/05/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
